Transnational Cannabis Ltd
OTC:TRCNF
Transnational Cannabis Ltd
OTC:TRCNF
Price:
0.0001
USD
Market Closed
Market Cap:
$10.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Transnational Cannabis Ltd
OTC:TRCNF
|
CA |
|
Jichodo Co Ltd
TSE:3597
|
JP |
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
TW |
|
T
|
Teco 2030 ASA
OSE:TECO
|
NO |
|
Inmobiliaria del Sur SA
MAD:ISUR
|
ES |
|
Internetworking and Broadband Consulting Co Ltd
TSE:3920
|
JP |
|
M
|
Mediplantex National Pharmaceutical JSC
VN:MED
|
VN |
|
Payright Ltd
ASX:PYR
|
AU |
|
T
|
Techno Medica Co Ltd
TSE:6678
|
JP |
|
M
|
Macpower CNC Machines Ltd
NSE:MACPOWER
|
IN |
|
Ymirlink Inc
TSE:4372
|
JP |
|
E
|
Elix Vintage Residencial SOCIMI SA
MAD:YVRS
|
ES |
|
Western Mining Co Ltd
SSE:601168
|
CN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of TRCNF.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TRCNF
Multiples-Based Value
Not Available
Multiples Across Competitors
TRCNF Competitors Multiples
Transnational Cannabis Ltd Competitors
Transnational Cannabis Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Transnational Cannabis Ltd
OTC:TRCNF
|
10.7m USD | 0 | -0.1 | -0.6 | -0.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD | 13.4 | 42.2 | 28.5 | 30.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
231.4B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.4B CHF | 5.1 | 20.7 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.7 | 7.9 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
89.3B GBP | 2.7 | 15.6 | 8.4 | 10.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
